NEW YORK (AP) â€” A healthcare market research publisher says global vaccine sales rose by a healthy 16 percent last year.
Kalorama Information reports that sales shot up to $22.1 billion, from $19 billion in 2008.
The firm's researchers are forecasting vaccine sales will rise at a compound annual rate of 9.7 percent during the next five years. That would push sales to roughly $35 billion.
Growth will be driven by wider use of current vaccines and introduction of new ones.
Kalorama publisher Bruce Carlson says for some pharmaceutical companies, "vaccines were the only bright spot in their portfolio in 2009."
The Kalorama report notes sales of children's vaccines, which account for more than half the market, are growing at a faster rate than adult vaccines.